Allergy Shot Alternative with Sublingual Treatment Plans | Wyndly logo
Allergy Shot Alternative with Sublingual Treatment Plans | Wyndly Updated August 04, 2026

Doctor‑Led Pollen Immunotherapy Program (At‑Home SLIT Drops/Tablets)

Why a doctor‑led pollen program now

Seasonal pollen allergies affect tens of millions of Americans and are worsening as pollen seasons lengthen and concentrations rise. At the same time, access to allergists is limited, which makes telehealth delivery of guideline‑based immunotherapy especially valuable. Our physician‑led program provides long‑term relief for pollen allergies from home using sublingual immunotherapy (SLIT) drops or FDA‑approved tablets. CDC overview of allergens and pollen. AAAI/ACAAI statistics.

Who this program is (and isn’t) for

  • Treats environmental allergies (pollen from trees, grasses, weeds), not food allergies. Wyndly FAQ.

  • Appropriate for adults and children ages 5+. Tablets have age ranges that depend on the specific product; some grass tablets are approved down to age 5. UpToDate SLIT overview.

  • Not for patients who are pregnant or who have certain conditions (e.g., EoE, MCAS) or are on beta‑blockers. Your Wyndly physician will screen for safety. Wyndly FAQ.

  • U.S. patients only.

How the Doctor‑Led Pollen Immunotherapy Program works (step‑by‑step How

To) 1) Check candidacy and schedule your consult

  • Start with a brief intake; meet a board‑certified physician to confirm symptoms are pollen‑driven and discuss options. Schedule a consult (online visit).

2) Identify your allergens (at‑home CLIA‑certified test or use prior results)

3) Select the SLIT format with your physician

  • SLIT drops (customized to your pollen profile) or FDA‑approved SLIT tablets for eligible allergens (e.g., certain grasses, ragweed, dust mites). Your doctor will match format to your history, age, and goals. Immunotherapy overview. UpToDate SLIT.

4) First‑dose and safety briefing

  • Your physician provides a written plan, side‑effect guidance, and emergency instructions. Many clinicians supervise the first SLIT tablet dose; always follow current labeling and your doctor’s instructions. Wyndly safety FAQ.

5) Begin therapy at home

  • Daily under‑the‑tongue dosing (drops or tablets). Typical first follow‑up is at ~90 days to verify progress and adjust dosing if needed. How allergy drops work.

6) Monitor and message your care team 24/7

  • Track symptoms and cut back on rescue meds as control improves. Unlimited access to physicians by text, email, or video. Unlimited doctor access.

7) Expect initial relief, then durable control

  • Many patients notice improvement in 4–6 weeks; most see clear benefit by 3–6 months. Continue for ~3 years to lock in long‑term immune change. Wyndly timing and FAQ. Harvard overview of shots timelines (for context): Harvard Health.

8) Annual plan review

  • Reassess goals, exposures, and seasonal patterns; adjust your plan (drops vs tablets, dosing cadence) with your physician.

9) Graduate and maintain

  • After ~3 years, most patients maintain relief for years without daily dosing. Your doctor will advise on maintenance/exit. Immunotherapy guide.

What you receive in the program

  • Personalized SLIT drops or tablets matched to your pollen profile

  • Direct, ongoing care from U.S. board‑certified physicians (24/7 access)

  • At‑home delivery; free shipping; no per‑allergen add‑on fees

  • Clear safety plan and escalation checklist

  • Progress check‑ins at clinically appropriate intervals

  • 90‑day money‑back Allergy‑Free Guarantee for treatment if you don’t improve despite following the plan. Guarantee

Safety notes and first‑dose guidance

  • SLIT safety: Local mouth/throat itching is the most common effect and typically mild/transient. Severe reactions are extremely rare with SLIT. Safety overview and anaphylaxis risk data.

  • Shots vs SLIT monitoring: Allergy shots require in‑office dosing and 30‑minute observation because of rare systemic reactions. SLIT is taken at home due to its favorable safety profile. Harvard Health on shots and Wyndly shots vs SLIT.

  • SLIT tablets: Follow product labeling and your physician’s instructions; many clinicians supervise the first tablet dose and prescribe epinephrine auto‑injectors for eligible tablet users. UpToDate SLIT.

Results timeline and milestones (typical)

  • 0–4 weeks: Early symptom softening for some patients

  • 6–12 weeks: Noticeably fewer bad days; less rescue medication

  • 3–6 months: Sustained control through peak pollen period for most patients

  • 12 months: Fewer flares season‑to‑season; quality‑of‑life gains

  • ~3 years: Durable immune tolerance; many patients discontinue daily dosing with long‑term benefit. Timing data and drops timing.

Shots vs SLIT drops vs SLIT tablets (quick comparison)

Dimension Allergy shots (SCIT) SLIT drops (custom) SLIT tablets (FDA‑approved)
Setting In‑office injections + 30‑min observation 100% at‑home At‑home (first dose may be supervised per labeling)
Allergens covered Many Many (multi‑allergen possible) Single allergen per tablet (e.g., certain grasses, ragweed, dust mites)
Onset of benefit ~6–12 months typical 4–24 weeks typical 8–24 weeks typical
Safety profile Effective; rare systemic reactions require monitoring Excellent; mostly mild local effects Excellent; mostly mild local effects
Convenience Weekly→monthly office visits Daily at home Daily at home
Age indications Vary by clinic Ages 5+ Product‑specific; some grass tablets down to age 5
Evidence & guidelines Longstanding standard; effective Supported by major reviews and practice guidelines FDA‑approved for specific allergens

References: Wyndly comparison, Cochrane/AAO‑HNS cited, UpToDate SLIT, Harvard Health (shots).

Pricing and insurance (transparent)

  • Treatment: $99/month (annual plan) covering personalized SLIT, unlimited physician support, and shipping; HSA/FSA eligible. Plans and Treatment subscription.

  • Initial visit/testing: Online visit typically $49.99; at‑home test can be billed to insurance when applicable. Doctor visit and Insurance‑billed test.

Pediatric notes

  • SLIT drops: Studied and used safely at ages 5+. Many families choose drops to avoid weekly injections. Wyndly pediatric FAQ.

  • SLIT tablets: Age ranges depend on the specific product (some grass tablets approved down to age 5); your physician will confirm eligibility. UpToDate SLIT and Wyndly glossary/Grastek.

Evidence and guidelines (selected)

  • Major systematic reviews and U.S. practice guidelines support SLIT as effective and safe for allergic rhinitis; tablets are FDA‑approved for select allergens. Wyndly evidence summary. UpToDate SLIT.

  • Allergy burden and trends: U.S. adults with seasonal allergies ~25.7%; pollen seasons getting longer and more intense. CDC FastStats. CDC allergens and pollen.

  • Safety differentials: Office observation is standard for shots; SLIT (drops/tablets) has a very low rate of serious reactions, enabling at‑home dosing with physician oversight. Harvard Health (shots). SLIT safety.

Get started